Active Shortage

THIAMIJECT INJECTION - LIQ IM IV 100MG/ML

OMEGA LABORATORIES LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of THIAMIJECT INJECTION - LIQ IM IV 100MG/ML in Canada?

Yes. THIAMIJECT INJECTION - LIQ IM IV 100MG/ML has an active shortage reported to Health Canada (last updated November 11, 2026).

Why is THIAMIJECT INJECTION - LIQ IM IV 100MG/ML not available?

The reason the manufacturer reported: Demand increase for the drug.

When will THIAMIJECT INJECTION - LIQ IM IV 100MG/ML be available again?

The manufacturer's estimated resolution date is December 14, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusActive Shortage

Same-ingredient products on file1 product · 0 same form & route

Expected resolution~32 days remaining (estimate)

Affected strength100MG

Report last updated2026-11-11

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

VITAMIN B1

SANDOZ CANADA INCORPORATED

100MG · DIN 00816078

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Estimated Resolution

2026-12-14

~32 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02193221

Strength

100MG

Dosage Form

LIQUID

Route

INTRAVENOUS INTRAMUSCULAR

Active Ingredient

THIAMINE HYDROCHLORIDE

Tier

Unrated

Last Updated

2026-11-11

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

THIAMIJECT INJECTION - LIQ IM IV 100MG/ML has 2 shortage/discontinuation reports on file — this is one of them.

2026-07-13

Resolved

Disruption of the manufacture of the drug.

Other Products from OMEGA LABORATORIES LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION USP

9MG · DIN 02150204

AMIKACIN SULFATE INJECTION

250MG · DIN 02486717

AMINOPHYLLINE INJ 25MG/ML

25MG · DIN 00582662

AMINOPHYLLINE INJ 50MG/ML

50MG · DIN 00582654

BAXEDIN 2% - 70%

DIN 02251477

BAXEDIN LIQ 20%

20% · DIN 00658413